Filing Details
- Accession Number:
- 0000899243-22-030183
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-01 16:28:39
- Reporting Period:
- 2022-09-01
- Accepted Time:
- 2022-09-01 16:28:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1832038 | Adagio Therapeutics Inc. | ADGI | Biological Products, (No Disgnostic Substances) (2836) | 851403134 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1875613 | David Hering | C/O Adagio Therapeutics, Inc. 1601 Trapelo Road, Suite 178 Waltham MA 02451 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-09-01 | 8,000 | $4.52 | 8,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price in Column 4 is a weighted average purchase price. The prices actually paid ranged from $4.515 to $4.52. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range.
Billionaire Hedge Funds
